Digital PCR (dPCR) and qPCR Market size is forecast to reach $6.7 billion by 2025, growing at a CAGR of 7.9% during the forecast period 2020-2025. Polymerase Chain Reaction(PCR) is method widely used to make millions to billions of copies of a specific DNA sample which allow scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail. Digital PCR is a biotechnological refinement of conventional PCR methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA. A real-time polymerase chain reaction, also known as quantitative PCR, is a laboratory technique of molecular biology based on the PCR. With growing incidences of infectious disease and a greater number of advancement in PCR techniques are few of the factors driving the demand of Digital PCR (dPCR) and qPCR during the forecast period 2020-2025.
Key Takeaways
- North America dominated the Digital PCR (dPCR) and qPCR Market in 2019 owing to the increase in research and developments by Pharmaceutical companies in this region.
- Increase incidence of infectious diseases along with genetic disorders globally, Advancements in PCR techniques and research activities are few factors that are driving the growth of the Digital PCR (dPCR) and qPCR.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Digital PCR (dPCR) and qPCR Market report.
Product- Segment Analysis
Based on the Product, Digital (dPCR) and Real Time (qPCR) is segmented into Reagents and Consumables, Instruments and Software. In 2019, Reagents and Consumables held largest share of Product segment. This is owing to various applications of Quantitative PCR with respect to traditional PCR techniques. However, instruments are set to be the fastest growing CAGR among digital PCR (dPCR) during the forecast period 2020-2025. This is owing to reduced throughput time, elimination of reference standard and higher accuracy offered by dPCR with respect to qPCR. Also, the growing demand of forensic and drug discovery for digital PCR is also increasing the demand during the forecast period 2020-2025.
Application-Segment Analysis
Based on the Application Digital (dPCR) and Real Time (qPCR) is segmented into Clinical, Research Applications and Forensic Applications. Research Applications holds highest share in 2019. This is owing to its application widely used for stem cell research, genetic and oncology research. However, Clinical segment is set to be fastest growing segment with a CAGR of 8.1% during the forecast period 2020-2025. This is owing to developments made in clinical laboratories and increase in adoption of automated process.
Geography-Segment Analysis
Based on the Geography Digital PCR (dPCR) and Real time PCR (qPCR) is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America accounted for largest market share of 41.15% in 2019 of overall market. This is owing to extensive R&D by Pharmaceutical companies in the region. Also, presence of maximum number of healthcare organization has attribute the demand of North America. However, Asia Pacific is set to be the fastest growing CAGR during the forecast period 2020-2025. This is owing to current expansion and modernization of healthcare infrastructure in countries such as China, India, and Japan. These countries are also increasing research projects in field of cancer, genomics, clinical research. Owing to these reasons the Digital PCR (dPCR) and qPCR is driving the demand in Asia Pacific countries.
Drivers- Digital PCR (dPCR) and qPCR Market
- Rising incidences of Infectious and Genetic Disorders
In US, hospitals report well over 5 million cases of recognised infectious disease related illness annually. The use of PCR in infectious disease diagnosis, has resulted in an ability to diagnose early and treat disease owing to a fastidious pathogen, determine the antimicrobial susceptibility of slow growing organisms, and ascertain the quantum of infection. This in thus is creating advancement of PCR techniques and is driving the growth of market during the forecast period 2020-2025.
Challenges- Digital PCR (dPCR) and qPCR Market
Factors such as high cost of commercial PCR systems in clinical diagnostics, lack of awareness and requirement of skilled labor are some of challenges restraining the growth of market during forecast period 2020-2025. Also, technical limitations of PCR are restriction the growth of market.
Digital PCR (dPCR) and qPCR-Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Digital PCR (dPCR) and qPCR Market. In 2019, Digital PCR (dPCR) and qPCR Market share is consolidated by the top ten players present in the market. Digital PCR (dPCR) and qPCR top 10 companies are Thermo Fisher Scientific, Inc, F. Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc, Takara Bio, Inc., Agilent Technologies, Inc., BioMérieux S.A, Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA among others.
Acquisitions/Product Launches
On May 2020, Thermofisher Scientific announced the acquisition with Qiagen for $11.5 Billion. This acquisition is set to provide developments and advancements in Digital PCR.
